Patents by Inventor Robin John

Robin John has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250122264
    Abstract: Protein constructs comprising a BTNL 3/8 targeting moiety, a payload and an optional linker are described herein. Pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Application
    Filed: October 30, 2024
    Publication date: April 17, 2025
    Inventors: Oliver NUSSBAUMER, Oxana POLYAKOVA, Raj MEHTA, Adrian HAYDAY, Pierre VANTOUROUT, Iva ZLATAREVA, Daisy MELANDRI, Robin John Campbell DART, Adam LAING
  • Publication number: 20250064489
    Abstract: Implantable devices for fixation of curved bone such as the pelvic ring pubic symphysis and acetabulum, and methods for the use of the devices are disclosed. The implantable devices are convertible between a flexible state and a rigid state, and include an elongate structure having a proximal bone interface, a main body, and a distal bone interface. In a flexible state, the devices may be inserted along, and conform to a curved pathway, and in the rigid state, the devices may support the mechanical loads required to fixate a fracture.
    Type: Application
    Filed: November 13, 2024
    Publication date: February 27, 2025
    Inventors: Edward Scott Harshman, Steven Charles Dimmer, Daniel Reed Baker, David Thomas Stinson, Robert N. Meek, Robin John Noel Coope, Lok Tin Lam
  • Patent number: 12167877
    Abstract: Implantable devices for fixation of curved bone such as the pelvic ring pubic symphysis and acetabulum, and methods for the use of the devices are disclosed. The implantable devices are convertible between a flexible state and a rigid state, and include an elongate structure having a proximal bone interface, a main body, and a distal bone interface. In a flexible state, the devices may be inserted along, and conform to a curved pathway, and in the rigid state, the devices may support the mechanical loads required to fixate a fracture.
    Type: Grant
    Filed: May 17, 2022
    Date of Patent: December 17, 2024
    Assignees: The University of British Columbia, British Columbia Cancer Agency Branch
    Inventors: Edward Scott Harshman, Steven Charles Dimmer, Daniel Reed Baker, David Thomas Stinson, Robert N. Meek, Robin John Noel Coope, Lok Tin Lam
  • Patent number: 12152064
    Abstract: Protein constructs comprising a BTNL3/8 targeting moiety, a payload and an optional linker are described herein. Pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: November 26, 2024
    Assignee: King's College London and GammaDelta Therapeutics Limited
    Inventors: Oliver Nussbaumer, Oxana Polyakova, Raj Mehta, Adrian Hayday, Pierre Vantourout, Iva Zlatareva, Daisy Melandri, Robin John Campbell Dart, Adam Laing
  • Publication number: 20240086430
    Abstract: A method can include, responsive to receipt of input characterizing a geologic environment, utilizing a trained machine learning model to identify a number of geologic environments that include corresponding data stored in at least one database; analyzing one or more of the number of geologic environments; and outputting a result based at least in part on the analyzing.
    Type: Application
    Filed: January 31, 2022
    Publication date: March 14, 2024
    Inventors: Robin John Pickles, Richard Torrens, Stephen Robert Freeman, Ranjit Vhanamane, Kwangwon Park
  • Publication number: 20240083269
    Abstract: A charge coupler with integrated electrical and mechanical disconnect switching can include a first member. A charging coupler can include a first member and a second member. The second member can be coupled at a first end with the first member. A charging coupler can include a first switch disposed at the first member and operable to cause, in response to a movement of the second member to a first angle with the first member that engages the first switch, a charging device to electrically decouple the charging device from a vehicle. A charging coupler can include a second switch disposed at the first member and operable to cause, in response to a movement of the second member to a second angle with the first member that engages the second switch, the charging device to mechanically decouple the charging device from the vehicle.
    Type: Application
    Filed: September 14, 2022
    Publication date: March 14, 2024
    Inventors: Nasser Noormohammadi, Kevin Sze, Tyler Jay Erikson, Travis Elliot Stewart, Alexander Michael Kwan, Kyle Robert Underhill, Kush Upreti, Ellen Marie Hilgersom, Robin John Moore
  • Patent number: 11920198
    Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing the method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: March 5, 2024
    Assignee: UNIVERSITY OF PRETORIA
    Inventors: Robin John Green, Refiloe Masekela, Cheryl Stewart, Michael Sean Pepper
  • Publication number: 20240044018
    Abstract: A process for producing solid carbon and gaseous oxygen from CO2 via electrolysis using an electrolysis apparatus is disclosed. The apparatus includes a chamber with an electrolyte inlet, an electrolyte outlet, a liquid electrolyte containing CO2 in the chamber, at least one cathode-anode pair, with the cathode including a liquid metal capable of catalysing reduction of CO2 to solid carbon at a selected operating temperature of the process. The process includes causing the electrolyte to flow from the inlet to the outlet in fluid communication with the cathode-anode pair, applying a voltage between the cathode-anode pair and causing solid carbon to form on the cathode from CO2 in the electrolyte and gaseous oxygen to be evolved at the anode from CO2 in the electrolyte.
    Type: Application
    Filed: November 26, 2021
    Publication date: February 8, 2024
    Inventors: Ali Zavabeti, Gang Li, Robin John Batterham, Rodney James Dry, Michael John Dry
  • Publication number: 20230157708
    Abstract: Devices for treating a bone and methods of inserting such devices into a bone are disclosed. A device for treating a bone may include a flexible tube, a stiffening mechanism and an actuator. The flexible tube has a distal end and a proximal end. The stiffening mechanism within the flexible tube is configured to cause the flexible tube to become rigid. The actuator is configured to cause the stiffening mechanism to cause the flexible tube to become rigid in response to the actuator being actuated.
    Type: Application
    Filed: November 16, 2022
    Publication date: May 25, 2023
    Inventors: Robert Meek, Qingan Zhu, Timothy Schwab, Robin John Noel Coope, Jared Slobodan, Scott Young
  • Publication number: 20220411431
    Abstract: This invention provides compounds of formula (I) and salts thereof, which have activity as inhibitors of N-myristoyl transferase (NMT). The invention also relates to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of N-myristoyl transferase provides a therapeutic or prophylactic effect, including protozoan infections (such as malaria and leishmaniasis), viral infections (such as human rhinovirus and HIV), and hyperproliferative disorders (such as B-cell lymphoma).
    Type: Application
    Filed: July 27, 2022
    Publication date: December 29, 2022
    Applicant: Imperial College Innovations Limited
    Inventors: Andrew Simon Bell, Edward William Tate, Robin John Leatherbarrow, Jennie Ann Hutton, James Antony Brannigan
  • Patent number: 11529148
    Abstract: Devices for treating a bone and methods of inserting such devices into a bone are disclosed. A device for treating a bone may include a flexible tube, a stiffening mechanism and an actuator. The flexible tube has a distal end and a proximal end. The stiffening mechanism within the flexible tube is configured to cause the flexible tube to become rigid. The actuator is configured to cause the stiffening mechanism to cause the flexible tube to become rigid in response to the actuator being actuated.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: December 20, 2022
    Assignees: The University of British Columbia, British Columbia Cancer Agency Branch
    Inventors: Robert Meek, Qingan Zhu, Timothy Schwab, Robin John Noel Coope, Jared Slobodan, Scott Young
  • Patent number: 11479468
    Abstract: A composition, which may be in the form of a film, comprises a network of carbon nanotubes. One or more non-conjugated polymer molecules are associated with individual carbon nanotubes or small bundles of carbon nanotubes in the form of polymer-nanotube complexes.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: October 25, 2022
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Giulio Mazzotta, Robin John Nicholas, Moritz Kilian Riede
  • Patent number: 11466011
    Abstract: This invention provides compounds of formula (I) and salts thereof, which have activity as inhibitors of N-myristoyl transferase (NMT). The invention also relates to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of N-myristoyl transferase provides a therapeutic or prophylactic effect, including protozoan infections (such as malaria and leishmaniasis), viral infections (such as human rhinovirus and HIV), and hyperproliferative disorders (such as B-cell lymphoma).
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: October 11, 2022
    Assignee: IMPERIAL COLLEGE INNOVATIONS LIMITED
    Inventors: Andrew Simon Bell, Edward William Tate, Robin John Leatherbarrow, Jennie Ann Hutton, James Antony Brannigan
  • Publication number: 20220287744
    Abstract: Implantable devices for fixation of curved bone such as the pelvic ring pubic symphysis and acetabulum, and methods for the use of the devices are disclosed. The implantable devices are convertible between a flexible state and a rigid state, and include an elongate structure having a proximal bone interface, a main body, and a distal bone interface. In a flexible state, the devices may be inserted along, and conform to a curved pathway, and in the rigid state, the devices may support the mechanical loads required to fixate a fracture.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 15, 2022
    Inventors: Edward Scott Harshman, Steven Charles Dimmer, Daniel Reed Baker, David Thomas Stinson, Robert N. Meek, Robin John Noel Coope, Lok Tin Lam
  • Patent number: 11369421
    Abstract: Implantable devices for fixation of curved bone such as the pelvic ring pubic symphysis and acetabulum, and methods for the use of the devices are disclosed. The implantable devices are convertible between a flexible state and a rigid state, and include an elongate structure having a proximal bone interface, a main body, and a distal bone interface. In a flexible state, the devices may be inserted along, and conform to a curved pathway, and in the rigid state, the devices may support the mechanical loads required to fixate a fracture.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: June 28, 2022
    Assignee: The University of British Columbia and British Columbia Cancer Agency Branch
    Inventors: Edward Scott Harshman, Steven Charles Dimmer, Daniel Reed Baker, David Thomas Stinson, Robert N. Meek, Robin John Noel Coope, Lok Tin Lam
  • Publication number: 20210340626
    Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing the method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.
    Type: Application
    Filed: July 13, 2021
    Publication date: November 4, 2021
    Inventors: Robin John GREEN, Refiloe MASEKELA, Cheryl STEWART, Michael Sean PEPPER
  • Publication number: 20210246187
    Abstract: Protein constructs comprising a BTNL3/8 targeting moiety, a payload and an optional linker are described herein. Pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Application
    Filed: June 5, 2019
    Publication date: August 12, 2021
    Inventors: Oliver NUSSBAUMER, Oxana POLYAKOVA, Raj MEHTA, Adrian HAYDAY, Pierre VANTOUROUT, Iva ZLATAREVA, Daisy MELANDRI, Robin John Campbell DART, Adam LAING
  • Patent number: 11060146
    Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing the method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: July 13, 2021
    Assignee: UNIVERSITY OF PRETORIA
    Inventors: Robin John Green, Refiloe Masekela, Cheryl Stewart, Michael Sean Pepper
  • Publication number: 20200369524
    Abstract: A composition, which may be in the form of a film, comprises a network of carbon nanotubes.
    Type: Application
    Filed: November 30, 2018
    Publication date: November 26, 2020
    Inventors: Giulio MAZZOTTA, Robin John NICHOLAS, Moritz Kilian RIEDE
  • Publication number: 20200339586
    Abstract: This invention provides compounds of formula (I) and salts thereof, which have activity as inhibitors of N-myristoyl transferase (NMT). The invention also relates to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of N-myristoyl transferase provides a therapeutic or prophylactic effect, including protozoan infections (such as malaria and leishmaniasis), viral infections (such as human rhinovirus and HIV), and hyperproliferative disorders (such as B-cell lymphoma).
    Type: Application
    Filed: July 8, 2020
    Publication date: October 29, 2020
    Applicant: Imperial College Innovations Limited
    Inventors: Andrew Simon Bell, Edward William Tate, Robin John Leatherbarrow, Jennie Ann Hutton, James Antony Brannigan